Gastrointestinal lesions associated with spondyloarthropathies

World Journal of Gastroenterology

Volumn 15, Issue 20, 2009, Pages 2443-2448

  Orlando, Ambrogio ^a   Renna, Sara ^a   Perricone, Giovanni ^a   Cottone, Mario ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Ankylosing spondylitis; Arthritis; Crohn's disease; Gastrointestinal diseases; Inflammation; Inflammatory bowel diseases; Nonsteroidal anti inflammatory drugs; Spondylosis

Indexed keywords

ANKYLOSING SPONDYLITIS; ARTICLE; BEHCET DISEASE; CELIAC DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENTERITIS; HUMAN; INTESTINE BYPASS; INTESTINE LIPODYSTROPHY; PARASITOSIS; PSEUDOMEMBRANOUS COLITIS; REACTIVE ARTHRITIS; SPONDYLOARTHROPATHY; GASTROINTESTINAL DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; REVIEW;

NONSTEROID ANTIINFLAMMATORY AGENT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; GASTROINTESTINAL DISEASES; HUMANS; INFLAMMATORY BOWEL DISEASES; SPONDYLARTHROPATHIES;

EID: 67650106558     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.2443     Document Type: Article

References (47)

1. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 1976; 55: 401-412
2. Rudwaleit M, Baeten D. Ankylosing spondylitis and bowel disease. Best Pract Res Clin Rheumatol 2006; 20: 451-471
3. Schorr-Lesnick B, Brandt LJ. Selected rheumatologic and dermatologic manifestations of inflammatory bowel disease. Am J Gastroenterol 1988; 83: 216-223
4. Wordsworth P. Arthritis and inflammatory bowel disease. Curr Rheumatol Rep 2000; 2: 87-88
5. Leirisalo-Repo M, Turunen U, Stenman S, Helenius P, Seppälä K. High frequency of silent inflammatory bowel disease in spondylarthropathy. Arthritis Rheum 1994; 37: 23-31
6. De Keyser F, Elewaut D, De Vos M, De Vlam K, Cuvelier C, Mielants H, Veys EM. Bowel inflammation and the spondyloarthropathies. Rheum Dis Clin North Am 1998; 24: 785-813, ix-x
7. Mielants H, Veys EM. The gut in the spondyloarthropathies. J Rheumatol 1990; 17: 7-10
8. De Keyser F, Baeten D, Van den Bosch F, De Vos M, Cuvelier C, Mielants H, Veys E. Gut inflammation and spondyloarthropathies. Curr Rheumatol Rep 2002; 4: 525-532
9. Mielants H, De Keyser F, Baeten D, Van den Bosch F. Gut inflammation in the spondyloarthropathies. Curr Rheumatol Rep 2005; 7: 188-194
10. Walker WA, Isselbacher KJ, Bloch KJ. Immunologic control of soluble protein absorption from the small intestine: a gut-surface phenomenon. Am J Clin Nutr 1974; 27: 1434-1440
11. Lubrano E, Ciacci C, Ames PR, Mazzacca G, Oriente P, Scarpa R. The arthritis of coeliac disease: prevalence and pattern in 200 adult patients. Br J Rheumatol 1996; 35: 1314-1318
12. Parke AL, Fagan EA, Chadwick VS, Hughes GR. Coeliac disease and rheumatoid arthritis. Ann Rheum Dis 1984; 43: 378-380
13. Kwo PY, Tremaine WJ. Nonsteroidal anti-inflammatory drug-induced enteropathy: case discussion and review of the literature. Mayo Clin Proc 1995; 70: 55-61
14. Bjarnason I, Hayllar J, MacPherson AJ, Russell AS. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993; 104: 1832-1847
15. Neutra MR, Pringault E, Kraehenbuhl JP. Antigen sampling across epithelial barriers and induction of mucosal immune responses. Annu Rev Immunol 1996; 14: 275-300
16. Weiner HL. Oral tolerance. Proc Natl Acad Sci USA 1994; 91: 10762-10765
17. Smith MD, Gibson RA, Brooks PM. Abnormal bowel permeability in ankylosing spondylitis and rheumatoid arthritis. J Rheumatol 1985; 12: 299-305
18. Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Meyer zum Büschenfelde KH. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995; 102: 448-455
19. Healy PJ, Helliwell PS. Classification of the spondyloarthropathies. Curr Opin Rheumatol 2005; 17: 395-399
20. Zeidler H, Brandt J, Schnarr S. Undifferentiated spondyloarthritis. In: Weisman MH, Reveille JD, van der Heijde D, editors. Ankylosing spondylitis and the spondyloarthropathies - a companion to rheumatology. 3rd ed. Philadelpha: Mosby, 2006: 75
21. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, Cats A, Dijkmans B, Olivieri I, Pasero G. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991; 34: 1218-1227
22. Amor B, Dougados M, Mijiyawa M. [Criteria of the classification of spondylarthropathies] Rev Rhum Mal Osteoartic 1990; 57: 85-89
23. Zochling J, Brandt J, Braun J. The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis. Rheumatology (Oxford) 2005; 44: 1483-1491
24. Rosenbaum JT. Characterization of uveitis associated with spondyloarthritis. J Rheumatol 1989; 16: 792-796
25. Gladman DD, Shuckett R, Russell ML, Thorne JC, Schachter RK. Psoriatic arthritis (PSA) - an analysis of 220 patients. Q J Med 1987; 62: 127-141
26. van der Paardt M, Crusius JB, de Koning MH, Murillo LS, van de Stadt RJ, Dijkmans BA, Peña AS, van der Horst-Bruinsma IE. CARD15 gene mutations are not associated with ankylosing spondylitis. Genes Immun 2003; 4: 77-78
27. Cuvelier C, Barbatis C, Mielants H, De Vos M, Roels H, Veys E. Histopathology of intestinal inflammation related to reactive arthritis. Gut 1987; 28: 394-401
28. Mielants H, Veys EM, De Vos M, Cuvelier C, Goemaere S, De Clercq L, Schatteman L, Elewaut D. The evolution of spondyloarthropathies in relation to gut histology. I. Clinical aspects. J Rheumatol 1995; 22: 2266-2272
29. Mielants H, Veys EM, Cuvelier C, De Vos M, Goemaere S, De Clercq L, Schatteman L, Elewaut D. The evolution of spondyloarthropathies in relation to gut histology. II. Histological aspects. J Rheumatol 1995; 22: 2273-2278
30. Mielants H, Veys EM, Cuvelier C, De Vos M, Goemaere S, De Clercq L, Schatteman L, Gyselbrecht L, Elewaut D. The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint. J Rheumatol 1995; 22: 2279-2284
31. Mielants H, Veys EM. [Significance of intestinal inflammation in the pathogenesis of spondylarthropathies] Verh K Acad Geneeskd Belg 1996; 58: 93-116
32. De Keyser F, Van Damme N, De Vos M, Mielants H, Veys EM. Opportunities for immune modulation in the spondyloarthropathies with special reference to gut inflammation. Inflamm Res 2000; 49: 47-54
33. Eliakim R, Karban A, Markovits D, Bardan E, Bar-Meir S, Abramowich D, Scapa E. Comparison of capsule endoscopy with ileocolonoscopy for detecting small-bowel lesions in patients with seronegative spondyloarthropathies. Endoscopy 2005; 37: 1165-1169
34. Conti F, Borrelli O, Anania C, Marocchi E, Romeo EF, Paganelli M, Valesini G, Cucchiara S. Chronic intestinal inflammation and seronegative spondyloarthropathy in children. Dig Liver Dis 2005; 37: 761-767
35. Brophy S, Mackay K, Al-Saidi A, Taylor G, Calin A. The natural history of ankylosing spondylitis as defined by radiological progression. J Rheumatol 2002; 29: 1236-1243
36. Inman RD. Arthritis and enteritis - an interface of protean manifestations. J Rheumatol 1987; 14: 406-410
37. Puéchal X. Whipple disease and arthritis. Curr Opin Rheumatol 2001; 13: 74-79
38. Hatemi G, Fresko I, Tascilar K, Yazici H. Increased enthesopathy among Beh&et's syndrome patients with acne and arthritis: an ultrasonography study. Arthritis Rheum 2008; 58: 1539-1545
39. Ceccarelli F, Priori R, Iagnocco A, Coari G, Accorinti M, Pivetti Pezzi P, Valesini G. Knee joint synovitis in Behçet's disease: a sonographic study. Clin Exp Rheumatol 2007; 25: S76-S79
40. Bjarnason I, Williams P, So A, Zanelli GD, Levi AJ, Gumpel JM, Peters TJ, Ansell B. Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs. Lancet 1984; 2: 1171-1174
41. Langman MJ, Morgan L, Worrall A. Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage. Br Med J (Clin Res Ed) 1985; 290: 347-349
42. Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med 1992; 327: 749-754
43. Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Zlotnick S, Fort JG. Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo. Clin Gastroenterol Hepatol 2005; 3: 133-141
44. Maiden L, Thjodleifsson B, Seigal A, Bjarnason II, Scott D, Birgisson S, Bjarnason I. Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study. Clin Gastroenterol Hepatol 2007; 5: 1040-1045
45. Matsuhashi N, Yamada A, Hiraishi M, Konishi T, Minota S, Saito T, Sugano K, Yazaki Y, Mori M, Shiga J. Multiple strictures of the small intestine after long-term nonsteroidal anti-inflammatory drug therapy. Am J Gastroenterol 1992; 87: 1183-1186
46. Graham DY, Opekun AR, Willingham FF, Qureshi WA. Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol 2005; 3: 55-59
47. Hayashi Y, Yamamoto H, Kita H, Sunada K, Sato H, Yano T, Iwamoto M, Sekine Y, Miyata T, Kuno A, Iwaki T, Kawamura Y, Ajibe H, Ido K, Sugano K. Non-steroidal anti-inflammatory drug-induced small bowel injuries identified by double-balloon endoscopy. World J Gastroenterol 2005; 11: 4861-4864